Sienna Biopharmaceuticals Inc
Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs in various therapeutic areas. It develops therapies in immunology and inflammation that target select pathways in tissues, such as skin. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical … Read more
Market Cap & Net Worth: Sienna Biopharmaceuticals Inc (SNNAQ)
Sienna Biopharmaceuticals Inc (PINK:SNNAQ) has a market capitalization of $3.09K ($3.09K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46715 globally and #14524 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sienna Biopharmaceuticals Inc's stock price $0.00 by its total outstanding shares 30907542 (30.91 Million).
Sienna Biopharmaceuticals Inc Market Cap History: 2017 to 2025
Sienna Biopharmaceuticals Inc's market capitalization history from 2017 to 2025. Data shows change from $560.97 Million to $3.09K (-79.45% CAGR).
Sienna Biopharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sienna Biopharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SNNAQ by Market Capitalization
Companies near Sienna Biopharmaceuticals Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Sienna Biopharmaceuticals Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Sienna Biopharmaceuticals Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, Sienna Biopharmaceuticals Inc's market cap moved from $560.97 Million to $ 3.09K, with a yearly change of -79.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.09K | 0.00% |
| 2024 | $3.09K | 0.00% |
| 2023 | $3.09K | 0.00% |
| 2022 | $3.09K | 0.00% |
| 2021 | $3.09K | -98.00% |
| 2020 | $154.54K | -84.47% |
| 2019 | $995.22K | -98.61% |
| 2018 | $71.71 Million | -87.22% |
| 2017 | $560.97 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sienna Biopharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.09K USD |
| MoneyControl | $3.09K USD |
| MarketWatch | $3.09K USD |
| marketcap.company | $3.09K USD |
| Reuters | $3.09K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.